The authors compared the clinical features between familial and sporadic cases of moyamoya disease (MMD) by retrospectively analyzing data on patients with MMD registered in the database of Tokyo Medical and Dental University over a period of 28 years.
In total, 383 patients with hospital records at Tokyo Medical and Dental University from 1980 to 2007 were registered into the database. The data on all of these patients were retrospectively reviewed to clarify the occurrence of familial cases. Clinical features of child or adolescent patients (< 20 years of age) with MMD were compared between familial and sporadic cases in a subgroup of patients who were registered after 1995, initially diagnosed using MR angiography, and assessed using an intelligence scale.
Familial occurrence was observed in 59 patients (15.4%) in 40 pedigrees. The clinical features of juvenile patients were analyzed in 124 patients, 22 (17.7%) of whom had familial histories. In comparison with the sporadic cases, patients with familial histories were significantly younger at onset (4.7 vs 6.6 years old), had significantly more cortical infarction (59.1% vs 25.5%), and had significantly more stenoocclusive lesions in the posterior cerebral artery (45.4% vs 24.5%). The rate of patients with intellectual disturbance (intelligence quotient < 75) was significantly larger in the familial cases (47.4%) than in the sporadic cases (17.8%).
This survey of the clinical features of familial MMD suggests that patients with familial MMD had a more serious clinical course in childhood than the sporadic MMD cases.
Abbreviations used in this paper:IQ = intelligence quotient; MMD = moyamoya disease; PCA = posterior cerebral artery.
FukuyamaYKawaiMOhsawaM[Clinical genetic analysis on idiopathic occlusion of the circle of Willis. 4th report,]. HandaH: [Annual Report (1985) of the Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare Japan.]TokyoJapanese Government1986. 33–37(Jpn)
MatsushimaYAoyagiMMasaokaHSuzukiROhnoK: Mental outcome following encephaloduroarteriosynangiosis in children with moyamoya disease with the onset earlier than 5 years of age. Childs Nerv Syst6:440–4431990
MiyatakeSTouhoHMiyakeNOhbaCDoiHSaitsuH: Sibling cases of moyamoya disease having homozygous and heterozygous c.14576G>A variant in RNF213 showed varying clinical course and severity. J Hum Genet57:804–8062012
NariaiTMatsushimaYImaeSTanakaYIshiiKSendaM: Severe haemodynamic stress in selected subtypes of patients with moyamoya disease: a positron emission tomography study. J Neurol Neurosurg Psychiatry76:663–6692005
NariaiTSuzukiRHirakawaKMaeharaTIshiiKSendaM: Vascular reserve in chronic cerebral ischemia measured by the acetazolamide challenge test: comparison with positron emission tomography. AJNR Am J Neuroradiol16:563–5701995
RoachESGolombMRAdamsRBillerJDanielsSDeveberG: Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke39:2644–26912008
ScottRMSmithJLRobertsonRLMadsenJRSorianoSGRockoffMA: Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg100:2 Suppl Pediatrics142–1492004
SuzukiRMatsushimaYTakadaYNariaiTWakabayashiSToneO: Changes in cerebral hemodynamics following encephalo-duro-arterio-synangiosis (EDAS) in young patients with moyamoya disease. Surg Neurol31:343–3491989